Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 673
Selected: 0
NCT IDTitle
NCT04100096A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
NCT00064454FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
NCT00036127Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
NCT04174365Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder
NCT05628103A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication
NCT01240668Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
NCT03892889A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
NCT02859402Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas
NCT05683340A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
NCT00041678Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
NCT02131415Real Life Assessment of Abilify Maintena
NCT00874497Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
NCT00996788Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis
NCT00705783Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT03734302The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects
NCT01634243A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients
NCT04369391A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.
NCT01410188Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
NCT01961882A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia
NCT02050854Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
NCT00002129A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3
NCT01284959Different Safety Profile of Risperidone and Paliperidone Extended-release
NCT03284177A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients
NCT01197066Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis
NCT01909466Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
NCT07184645A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis
NCT00043771Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
NCT03850509Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
NCT01942083A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)
NCT01360866Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
NCT06973577P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
NCT01890694Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
NCT01939353Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder
NCT00043758Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT01413178A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
NCT01396421Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
NCT00664014A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia
NCT01292304Tolvaptan for Ascites in Cirrhotic Patients
NCT00948090PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
NCT00731549Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT01150162Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation
NCT04812379Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)
NCT01870999A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot
NCT01940159A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
NCT01670279Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
NCT03487770Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
NCT01981811Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
NCT02091882Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)
NCT05923892Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
NCT02730390Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance